ANIP ANI Pharmaceuticals

添加自選

65.360
+0.410+0.63%

收盤價 04/26 16:00 (美東)

67.310
+1.950+2.98%

盤後 19:29 (美東)

13.71億總市值76.89市盈率TTM

關於ANI Pharmaceuticals公司

ANI Pharmaceuticals Inc 開發、製造和銷售仿製藥。它生產液體、粉末和口服固體劑量產品。其產品開發領域包括麻醉劑、溶瘤劑、激素和類固醇，以及涉及緩釋和組合產品的複雜配方。它的一些通用產品包括紅黴素琥珀酸乙酯、甲基睾酮酯化雌激素 (EEMT)、依託度酸非諾貝特、氟伏沙明、氫化可的松灌腸劑和萬古黴素。它的地理部門是美國和加拿大，其中大部分收入來自美國。

公司介紹

公司代碼ANIP

公司名稱ANI Pharmaceuticals

上市日期2003/10/01

成立日期1996

CEOMr. Nikhil Lalwani

所屬市場納斯達克

員工數量642

證券類型海外普通股

年結日12-31

公司地址210 Main Street West

城市Baudette

省份明尼蘇達州

國家美國

郵編56623

電話1-218-634-3500

網址http://www.anipharmaceuticals.com

董事高管

姓名
職務
年薪

Nikhil Lalwani
Director, President and Chief Executive Officer
807.84萬

Krista Davis
Senior Vice President and Chief Human Resources Officer
--

Stephen P. Carey
Senior Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
257.61萬

Meredith W. Cook
Senior Vice President, General Counsel and Corporate Secretary
--

Christopher Mutz
Senior Vice President and Head of Rare Diseases
191.45萬

Ori Gutwerg
Senior Vice President, Generics
194.17萬

James G. Marken
Senior Vice President, Operations and Product Development
187.45萬

Thomas Rowland
Senior Vice President, Corporate Development & Strategy
--

Chad Gassert
Senior Vice President, Corporate Development and Strategy
189.62萬

Patrick D. Walsh
Chairman of the Board
42.22萬

Matthew J. Leonard
Director
92.83萬

Muthusamy Shanmugam
Director, Head of Research and Development and Chief Operating Office, Novitium Operations
--

Jeanne Thomas
Independent Director
39.58萬

Dr. Renee P. Tannenbaum
Independent Director
39.24萬

Dr. David B. Nash, M.B.A.,M.D.
Independent Director
40.72萬

Thomas J. Haughey
Independent Director
41.22萬

Antonio R. Pera
Independent Director
39.33萬

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

美股

綜合熱度